Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

No treatment fully prevents hair loss from chemotherapy yet.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Silver nanoparticles may reduce chemotherapy side effects and improve cancer treatment.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

EGFR inhibitors for lung cancer can cause severe skin issues.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Cancer prevention has advanced significantly, with some strategies proving successful.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.